Quantification of Fas protein in CSF of patients with neurocysticercosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S0004-282X2012000400007 http://repositorio.unifesp.br/handle/11600/7041 |
Resumo: | Neurocysticercosis is a parasitic disease that affects the central nervous system. The objective of this study was to investigate the correlation between neuronal death evaluated by the quantification of Fas apoptotic factor and the different evolutive forms of neurocysticercosis accompanied or not by epileptic seizures. METHODS: Cerebrospinal fluid samples from 36 patients with a diagnosis of neurocysticercosis divided into the following groups: active cystic form (n=15), 9 patients with and 6 without seizures, and calcified form (=21), 9 with and 12 without seizures. Fourteen patients comprised the control group. Fas protein concentrations were determined by ELISA. RESULTS: Only the group of patients with calcified cysts without seizures presented cerebrospinal fluid levels of Fas similar to those of the control group. Higher levels were observed for the other groups. CONCLUSIONS: The present finding suggests high cerebrospinal fluid levels of soluble Fas protein, except for patients with calcified cysts without seizures. Significant differences were observed for the group with calcified cysts and seizures, suggesting greater neuronal damage in these patients. Replacement of the term inactive cyst with reactive inactive cyst is suggested. |
id |
UFSP_d2c350bfac951c73c86fd6185163d73f |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/7041 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Quantification of Fas protein in CSF of patients with neurocysticercosisQuantificação da proteína Fas no LCR de pacientes com neurocisticercoseneurocysticercosisFas ligand proteincerebrospinal fluidneuronal damageneurocisticercoseproteína ligante Faslíquido cefalorraquidianodano neuronalNeurocysticercosis is a parasitic disease that affects the central nervous system. The objective of this study was to investigate the correlation between neuronal death evaluated by the quantification of Fas apoptotic factor and the different evolutive forms of neurocysticercosis accompanied or not by epileptic seizures. METHODS: Cerebrospinal fluid samples from 36 patients with a diagnosis of neurocysticercosis divided into the following groups: active cystic form (n=15), 9 patients with and 6 without seizures, and calcified form (=21), 9 with and 12 without seizures. Fourteen patients comprised the control group. Fas protein concentrations were determined by ELISA. RESULTS: Only the group of patients with calcified cysts without seizures presented cerebrospinal fluid levels of Fas similar to those of the control group. Higher levels were observed for the other groups. CONCLUSIONS: The present finding suggests high cerebrospinal fluid levels of soluble Fas protein, except for patients with calcified cysts without seizures. Significant differences were observed for the group with calcified cysts and seizures, suggesting greater neuronal damage in these patients. Replacement of the term inactive cyst with reactive inactive cyst is suggested.Neurocisticercose é uma doença parasitária que afeta o sistema nervoso central. O objetivo deste estudo foi investigar a correlação entre morte neuronal por meio da quantificação do fator apoptótico Fas e a presença de neurocisticercose nas suas diferentes fases evolutivas, acompanhadas ou não de crises epilépticas. MÉTODOS: Foram analisadas amostras de líquido cefalorraquidiano em 36 pacientes com diagnóstico de neurocisticercose, determinando-se as concentrações da proteína Fas pelo método ELISA. Foram considerados os seguintes grupos: forma cística ativa n=15 (9 com crises, 6 sem crises), forma calcificada n=21 (9 com crises, 12 sem crises) e 14 pacientes (grupo controle). RESULTADOS: Apenas o grupo com calcificações sem crises apresentou níveis de Fas semelhantes ao controle. Maiores níveis foram observados nos outros grupos. CONCLUSÕES: As formas ativa e calcificada apresentam níveis elevados da proteína Fas, exceto para as formas calcificadas sem crises. No grupo de calcificações com crise, observamos diferenças mais expressivas, sugerindo maior dano neuronal. Sugerimos a substituição da denominação cisto inativo por cisto inativo reagente.Universidade Federal de São Paulo (UNIFESP) Hospital São Paulo Departamento de Neurologia e NeurocirurgiaUNIFESP, Hospital São Paulo Depto. de Neurologia e NeurocirurgiaSciELOAcademia Brasileira de Neurologia - ABNEUROUniversidade Federal de São Paulo (UNIFESP)Camargo, José Augusto [UNIFESP]Bertolucci, Paulo Henrique Ferreira [UNIFESP]2015-06-14T13:43:41Z2015-06-14T13:43:41Z2012-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion262-266application/pdfhttp://dx.doi.org/10.1590/S0004-282X2012000400007Arquivos de Neuro-Psiquiatria. Academia Brasileira de Neurologia - ABNEURO, v. 70, n. 4, p. 262-266, 2012.10.1590/S0004-282X2012000400007S0004-282X2012000400007.pdf0004-282XS0004-282X2012000400007http://repositorio.unifesp.br/handle/11600/7041WOS:000302889200007engArquivos de Neuro-Psiquiatriainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T04:46:52Zoai:repositorio.unifesp.br/:11600/7041Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T04:46:52Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Quantification of Fas protein in CSF of patients with neurocysticercosis Quantificação da proteína Fas no LCR de pacientes com neurocisticercose |
title |
Quantification of Fas protein in CSF of patients with neurocysticercosis |
spellingShingle |
Quantification of Fas protein in CSF of patients with neurocysticercosis Camargo, José Augusto [UNIFESP] neurocysticercosis Fas ligand protein cerebrospinal fluid neuronal damage neurocisticercose proteína ligante Fas líquido cefalorraquidiano dano neuronal |
title_short |
Quantification of Fas protein in CSF of patients with neurocysticercosis |
title_full |
Quantification of Fas protein in CSF of patients with neurocysticercosis |
title_fullStr |
Quantification of Fas protein in CSF of patients with neurocysticercosis |
title_full_unstemmed |
Quantification of Fas protein in CSF of patients with neurocysticercosis |
title_sort |
Quantification of Fas protein in CSF of patients with neurocysticercosis |
author |
Camargo, José Augusto [UNIFESP] |
author_facet |
Camargo, José Augusto [UNIFESP] Bertolucci, Paulo Henrique Ferreira [UNIFESP] |
author_role |
author |
author2 |
Bertolucci, Paulo Henrique Ferreira [UNIFESP] |
author2_role |
author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Camargo, José Augusto [UNIFESP] Bertolucci, Paulo Henrique Ferreira [UNIFESP] |
dc.subject.por.fl_str_mv |
neurocysticercosis Fas ligand protein cerebrospinal fluid neuronal damage neurocisticercose proteína ligante Fas líquido cefalorraquidiano dano neuronal |
topic |
neurocysticercosis Fas ligand protein cerebrospinal fluid neuronal damage neurocisticercose proteína ligante Fas líquido cefalorraquidiano dano neuronal |
description |
Neurocysticercosis is a parasitic disease that affects the central nervous system. The objective of this study was to investigate the correlation between neuronal death evaluated by the quantification of Fas apoptotic factor and the different evolutive forms of neurocysticercosis accompanied or not by epileptic seizures. METHODS: Cerebrospinal fluid samples from 36 patients with a diagnosis of neurocysticercosis divided into the following groups: active cystic form (n=15), 9 patients with and 6 without seizures, and calcified form (=21), 9 with and 12 without seizures. Fourteen patients comprised the control group. Fas protein concentrations were determined by ELISA. RESULTS: Only the group of patients with calcified cysts without seizures presented cerebrospinal fluid levels of Fas similar to those of the control group. Higher levels were observed for the other groups. CONCLUSIONS: The present finding suggests high cerebrospinal fluid levels of soluble Fas protein, except for patients with calcified cysts without seizures. Significant differences were observed for the group with calcified cysts and seizures, suggesting greater neuronal damage in these patients. Replacement of the term inactive cyst with reactive inactive cyst is suggested. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-04-01 2015-06-14T13:43:41Z 2015-06-14T13:43:41Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0004-282X2012000400007 Arquivos de Neuro-Psiquiatria. Academia Brasileira de Neurologia - ABNEURO, v. 70, n. 4, p. 262-266, 2012. 10.1590/S0004-282X2012000400007 S0004-282X2012000400007.pdf 0004-282X S0004-282X2012000400007 http://repositorio.unifesp.br/handle/11600/7041 WOS:000302889200007 |
url |
http://dx.doi.org/10.1590/S0004-282X2012000400007 http://repositorio.unifesp.br/handle/11600/7041 |
identifier_str_mv |
Arquivos de Neuro-Psiquiatria. Academia Brasileira de Neurologia - ABNEURO, v. 70, n. 4, p. 262-266, 2012. 10.1590/S0004-282X2012000400007 S0004-282X2012000400007.pdf 0004-282X S0004-282X2012000400007 WOS:000302889200007 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Arquivos de Neuro-Psiquiatria |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
262-266 application/pdf |
dc.publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268318710759424 |